Topic Archives: Manitowoc (MTW)

January 30, 2017 / Travis Johnson, Stock Gumshoe

What’s Skousen’s First “Trump Trade” — Infrastructure Boom Stock Teased by new 1600 Alert service

Mark Skousen is an old hand in newsletterdom now, and we’ve looked at pitches for his newsletters that are published by Eagle Financial many times over the years, including the “entry level” Forecasts & Strategies letter as well as his more expensive options-focused services. And he’s launching a new service to take advantage of the […]

Comments

Travis Johnson, Stock Gumshoe on Lichtenfeld: “I See a 4,150% Earnings Setup in This $6 Biotech” / Nov 5, 10:26am

Finally worked out for hopeful PACB shareholders... as long as you didn't buy during late 2015 or 2016. I have no idea ...

Travis Johnson, Stock Gumshoe on Examining McCall’s “The First Trillion Dollar Patent Will Release the Largest Royalty Payments Ever Known to Mankind” pitch / Oct 1, 8:26pm

No, they sell DNA sequencing equipment... you can’t edit what you don’t know, eh? Folks have pitched ILMN as a “...

archegos2691 on Extreme Fortunes / Mar 5, 4:46pm

Hank, The biotech stocks are too risky for me as I do not understand the market and do not have any contacts/references...

rlamore on Special Comment: Update from $ARTH CEO Terrence Norchi, MD, MBA / Dec 8, 12:05pm

$MOTELY Fool's top 4 BIO Pics for 2018. Just got a teaser ad for the MF Explorer investment newsletter. They are nomin...

chris27 on The Rest of the 12 Biotechs of Christmas / Mar 20, 5:40am

$GNMX: Hello Everyone, I wanted to share this pertinent ADHD article on Genome-wide Copy Number Verification (CNV) map...

Roger on The Twelve Biotechs of Christmas: One / Jan 18, 2:50pm

I don't know if this article from Fierce Biotech of Jan 18 has been mentioned in reference to $BIOC (long). Bio-Rad h...

adadfarm on The Twelve Biotechs of Christmas: One / Jan 6, 1:07pm

2016 Illumina spinout, Grail, apparently raised $100 million in Series A financing from Bill Gates, Amazon founder Jeff...

Exvestor on What’s the “Fingerprint of Life” Machine that (Oxford Says) can Generate 500% Short Term Gains? / Dec 27, 10:48am

A class action suit was filed against the company on Dec. 16, 2016, one in NY, one in the U.S. District Court for the So...

jabberwocky on Sea of Tranquility / Oct 11, 2:35pm

Forgot to mention, no position in Genfit, Merck, or Illumina....

JohnM on Sea of Tranquility / Oct 11, 1:11am

Illumina Again Preannounces Q3 Revenue Shortfall; Shares Plunge Gene sequencer Illumina (ILMN) preannounced a Q3...

SoGiAm on Ten Common Biotech Investing Mistakes / Aug 19, 1:34am

$TMO, ILMN np: Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation Thermo Fisher Scientific (TMO) has re...

SoGiAm on “It could be the biggest medical breakthrough of the decade…” Teased by Private Briefing / Jun 2, 12:27am

$ILMN no position - A bit off topic for our west coast folks: Illumina To Produce Genome Sequencer For California Mark...

Chris on Looking for Motley Fool’s “Is This New IPO Stock the Next 100-Bagger?” / Apr 22, 3:28pm

Illumina or Match is the stock Motley is hinting at?...

backoffice on Looking for Motley Fool’s “Is This New IPO Stock the Next 100-Bagger?” / Apr 21, 7:47pm

I called them up and was told it was Illumina...

Mike Kapella on written by reader

What’ Motley Fool’s new double down stock. / Apr 18, 1:02am

The Gardner double down is ilmm illumina, the San Diego based genetic sequencing giant. ilmm has just created Grail, a ...

Mike Volpe on Hilary Kramer’s “New King of the Post-PC Era” / Mar 27, 4:42pm

Hey Ben, Dr. Skousen said by Cubist Pharmacuticals at $12.00 and at its high I think it was around $68.00, now its hoove...

vivian lewis on Lichtenfeld: “I See a 4,150% Earnings Setup in This $6 Biotech” / Jan 12, 5:27pm

I own Illumina (a US share) and Thermo Fisher (a US share) for one simple reason: I couldn't find any ADRs with the same...

newby3867 on Biotech Dim Sum: ARTH, CLDN, ESPR, BLRX, GILD and a New Baby Biotech for 2015 / Jan 12, 9:50am

Maybe a little competition for Illumina. http://www.forbes.com/sites/luketimmerman/2015/01/12/stealthy-10x-genomics-rai...

Frenchy on written by reader

Oxidation for Health…Physical and Fiscal / Aug 30, 5:13pm

Is this an interesting "pick and shovel play" in the biotech sector? Basically personalized medicine via genetics? Acc...

tanglewood on written by reader

NASH: An All-Too-Common Liver Disease and a Company Aiming to Treat It / Mar 16, 10:00pm

I subscribe to the magazine MIT Technology Review. On the cover of the current issue 'The Smartest Company in the World ...

Naquadah on written by reader

Oxford Club teaser: ‘Most Hated Industry in America’ / Feb 29, 7:33am

The first one is Illumina, Inc. (ILMN). Last year Revenue $902 million and net income $124,891,000. Net income in 2008 w...

Mario Vetroberg on “Inside the Vortex of a Historic Windfall” / Aug 13, 11:02am

I love the gene sequencing idea. Illumina has had some success, but there are many new technologies. There are very many...

Donnie Bean on “Inside the Vortex of a Historic Windfall” / Aug 1, 12:50pm

What a fantastic article. After reading the Motley Fool report, I analyzed many of same stocks mentioned here, and I ha...